Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo

• Published in: PloS one 2019-12, Vol.14 (12), p.e0225931-e0225931
• Main Authors: Shibata, Yuki, Yasui, Hironobu, Higashikawa, Kei, Miyamoto, Naoki, Kuge, Yuji
• Format: Article
• Language: English
• Subjects: Adenocarcinoma; Analysis; Animals; Antineoplastic agents; Antineoplastic Agents - pharmacology; Antioxidants; Antioxidants (Nutrients); Apoptosis; Biochemistry; Biology; Biology and Life Sciences; Biotechnology; Cancer; Cancer cells; Cancer research; Cancer therapies; Cancer treatment; Cell death; Cell Line, Tumor; Chemotherapy; Cysteine; Cystine; Depletion; Disease Models, Animal; Drug dosages; Engineering; Epidermal growth factor; Female; Ferroptosis; Ferroptosis - drug effects; Glutamate; Glutathione; Glutathione - metabolism; Glutathione peroxidase; Homeostasis; Humans; In vivo methods and tests; Inducers; Iron; Irradiation; Lung cancer; Medical schools; Medicine and Health Sciences; Metabolism; Oncology; Oxidative stress; Peroxidase; Piperazines - pharmacology; Radiation; Radiation (Physics); Radiation therapy; Radiation-Sensitizing Agents - pharmacology; Radiosensitivity; Radiotherapy; Research and Analysis Methods; Software industry; Starvation; Tumor cell lines; Tumors; Veterinary medicine; X ray irradiation; X rays; Xenograft Model Antitumor Assays; Xenografts; Xenotransplantation
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0225931

High concentrations of antioxidants in cancer cells are huge obstacle in cancer radiotherapy. Erastin was first discovered as an inducer of iron-dependent cell death called ferroptosis accompanied by antioxidant depletion caused by cystine glutamate antiporter inhibition. Therefore, treatment with erastin is expected to potentially enhance cellular radiosensitivity. In this study, we investigated the influence of treatment with erastin on the radiation efficiency against cancers. The clonogenic ability, glutathione peroxidase 4 (GPX4) expression, and glutathione concentration were evaluated using HeLa and NCI-H1975 adenocarcinoma cell lines treated with erastin and/or X-ray irradiation. For in vivo studies, NCI-H1975 cells were transplanted in the left shoulder of nude mice, and then radiosensitizing effect of erastin and glutathione concentration in the cancer were evaluated. Treatment with erastin induced ferroptosis and decreased the concentration of glutathione and GPX4 protein expression levels in the two tumor cell lines. Moreover, erastin enhanced X-ray irradiation-induced cell death in both human tumor cell lines. Furthermore, erastin treatment of a tumor-transplanted mouse model similarly demonstrated the radiosensitizing effect and decrease in intratumoral glutathione concentration in the in vitro study. In conclusion, our study demonstrated the radiosensitizing effect of erastin on two adenocarcinoma cell lines and the tumor xenograft model accompanied by glutathione depletion, indicating that ferroptosis inducers that reduce glutathione concentration could be applied as a novel cancer therapy in combination with radiotherapy.